273 related articles for article (PubMed ID: 20425038)
21. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
[TBL] [Abstract][Full Text] [Related]
23. [Treatment for low grade glioma focusing on grade II glioma].
Kayama T; Mouri W; Sakurada K; Sato S
No To Shinkei; 2005 Dec; 57(12):1035-42. PubMed ID: 16375188
[No Abstract] [Full Text] [Related]
24. [Low-grade gliomas in adults].
Kratzsch T; Gautschi OP; Kuhn SA; Hottinger AF; Hildebrandt G; Stienen MN
Praxis (Bern 1994); 2014 Nov; 103(23):1385-96. PubMed ID: 25391745
[TBL] [Abstract][Full Text] [Related]
25. Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome.
Shields LB; Choucair AK
World Neurosurg; 2014; 82(1-2):e299-309. PubMed ID: 24560709
[TBL] [Abstract][Full Text] [Related]
26. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
Clin Transl Oncol; 2018 Jan; 20(1):3-15. PubMed ID: 29124520
[TBL] [Abstract][Full Text] [Related]
27. SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma.
Gnekow AK; Kandels D; Tilburg CV; Azizi AA; Opocher E; Stokland T; Driever PH; Schouten-van Meeteren AYN; Thomale UW; Schuhmann MU; Czech T; Goodden JR; Warmuth-Metz M; Bison B; Avula S; Kortmann RD; Timmermann B; Pietsch T; Witt O
Klin Padiatr; 2019 May; 231(3):107-135. PubMed ID: 31108561
[TBL] [Abstract][Full Text] [Related]
28. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
Sturm D; Pfister SM; Jones DTW
J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
[TBL] [Abstract][Full Text] [Related]
30. Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T; Lim DH; Seol HJ; Park CK; Kim IH; Chang JH; Lee J; Jung S; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
J Neurooncol; 2018 Jul; 138(3):667-677. PubMed ID: 29572674
[TBL] [Abstract][Full Text] [Related]
31. Treatment options and neurocognitive outcome in patients with diffuse low-grade glioma.
Klein M
J Neurosurg Sci; 2015 Dec; 59(4):383-92. PubMed ID: 26375636
[TBL] [Abstract][Full Text] [Related]
32. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
33. Intracranial ependymomas of childhood: current management strategies.
Smyth MD; Horn BN; Russo C; Berger MS
Pediatr Neurosurg; 2000 Sep; 33(3):138-50. PubMed ID: 11096361
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors and survival study in high-grade glioma in the elderly.
Álvarez de Eulate-Beramendi S; Álvarez-Vega MA; Balbin M; Sanchez-Pitiot A; Vallina-Alvarez A; Martino-González J
Br J Neurosurg; 2016 Jun; 30(3):330-6. PubMed ID: 26828095
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.
Wang T; Gao T; Niu X; Xing X; Yang Y; Liu Y; Mao Q
World Neurosurg; 2018 Jun; 114():e218-e223. PubMed ID: 29524717
[TBL] [Abstract][Full Text] [Related]
36. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Stupp R; Tonn JC; Brada M; Pentheroudakis G;
Ann Oncol; 2010 May; 21 Suppl 5():v190-3. PubMed ID: 20555079
[No Abstract] [Full Text] [Related]
37. [An evidence based strategy for WHO Grade II Gliomas].
Narita Y
No Shinkei Geka; 2013 Jul; 41(7):565-81. PubMed ID: 23824347
[No Abstract] [Full Text] [Related]
38. Neurocognitive Function Following Therapy for Low-Grade Gliomas.
McAleer MF; Brown PD
Semin Radiat Oncol; 2015 Jul; 25(3):210-8. PubMed ID: 26050592
[TBL] [Abstract][Full Text] [Related]
39. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
Etxaniz O; Carrato C; de Aguirre I; Queralt C; Muñoz A; Ramirez JL; Rosell R; Villà S; Diaz R; Estival A; Teixidor P; Indacochea A; Ahjal S; Vilà L; Balañá C
J Neurooncol; 2017 Nov; 135(2):273-284. PubMed ID: 28884377
[TBL] [Abstract][Full Text] [Related]
40. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
